Q1 2022 · —
Revenue—
Net Income-$23.84M-$23.84M N/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$1.58-$1.58 no prior Q1 2021 on fileno prior Q4 2021 on file
Operating Income-$19,898,000—
Operating Cash Flow-$50,793,000—
Free Cash Flowderived-$52,481,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$23.84M | -$86.66M |
| EPS Diluted | -$1.58 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR